LingyiMed Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 10

LingyiMed General Information

Description

Developer of biotechnology materials designed for pharmaceutical research and clinical application purposes. The company operates a functional validation platform for rare disease animal models dedicated to innovated source, focusing on metabolic, CNS, ophthalmic, and other genetic rare diseases, enabling effective detection of rare disease in animals.

Contact Information

Formerly Known As
Shanghai Lingyi Biotechnology Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1006, Building 7, Phase I, Qianwan Bioport
  • Number 3300 Benjing Avenue, Ningwei Street, Xiaoshan District
  • Hangzhou, Zhejiang 900000
  • China
+86 153
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Room 1006, Building 7, Phase I, Qianwan Bioport
  • Number 3300 Benjing Avenue, Ningwei Street, Xiaoshan District
  • Hangzhou, Zhejiang 900000
  • China
+86 153

LingyiMed Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LingyiMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 04-Dec-2025 Completed Generating Revenue
6. Early Stage VC 16-Jul-2025 Completed Generating Revenue
5. Early Stage VC (Series A1) 25-Nov-2024 Completed Generating Revenue
4. Secondary Transaction - Private 27-Jul-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 05-May-2023 Completed Generating Revenue
2. Early Stage VC 09-Jun-2022 $14.9M $14.9M Completed Generating Revenue
1. Early Stage VC 05-Aug-2021 Completed Startup
To view LingyiMed’s complete valuation and funding history, request access »

LingyiMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LingyiMed Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hangzhou Capital Government Minority
Zhejiang Jolly Pharmaceutical Company Corporation Minority
Gisway Corporation Minority
HJ-Investment Venture Capital Minority
Holley Group Corporation Minority
You’re viewing 5 of 10 investors. Get the full list »

LingyiMed FAQs

  • When was LingyiMed founded?

    LingyiMed was founded in 2021.

  • Where is LingyiMed headquartered?

    LingyiMed is headquartered in Hangzhou, China.

  • What is the size of LingyiMed?

    LingyiMed has 40 total employees.

  • What industry is LingyiMed in?

    LingyiMed’s primary industry is Biotechnology.

  • Is LingyiMed a private or public company?

    LingyiMed is a Private company.

  • What is LingyiMed’s current revenue?

    The current revenue for LingyiMed is .

  • How much funding has LingyiMed raised over time?

    LingyiMed has raised $29.4M.

  • Who are LingyiMed’s investors?

    Hangzhou Capital, Zhejiang Jolly Pharmaceutical Company, Gisway, HJ-Investment, and Holley Group are 5 of 10 investors who have invested in LingyiMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process